83 related articles for article (PubMed ID: 2068174)
1. VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie Pédiatrique.
Frappaz D; Michon J; Hartmann O; Bouffet E; Gentet JC; Chastagner P; Sariban E; Brugière L; Rubie H; Lejars O
Prog Clin Biol Res; 1991; 366():561-6. PubMed ID: 2068174
[No Abstract] [Full Text] [Related]
2. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
[TBL] [Abstract][Full Text] [Related]
3. High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastoma.
Castello MA; Donfrancesco A; Clerico A; Cozza R; Dominici C; De Laurentis C; Properzi E; De Sio L; Schiavetti A; Deb G
Prog Clin Biol Res; 1991; 366():535-42. PubMed ID: 2068170
[No Abstract] [Full Text] [Related]
4. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Doz F; Neuenschwander S; Plantaz D; Courbon B; Gentet JC; Bouffet E; Mosseri V; Vannier JP; Mechinaud F; Desjardins L
J Clin Oncol; 1995 Apr; 13(4):902-9. PubMed ID: 7707117
[TBL] [Abstract][Full Text] [Related]
5. Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Michon J; Plantaz D; Peyroulet MC; Coze C; Frappaz D; Chastagner P; Baranzelli MC; Méchinaud F; Boutard P; Lutz P; Perel Y; Leverger G; de Lumley L; Millot F; Stéphan JL; Margueritte G; Hartmann O
Br J Cancer; 1998 Jun; 77(12):2310-7. PubMed ID: 9649151
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin activity in cisplatin treated neuroblastoma.
Lewis IJ; Stevens MC; Pearson AD; Pinkerton CR; Barnes JM
Prog Clin Biol Res; 1991; 366():553-9. PubMed ID: 2068173
[No Abstract] [Full Text] [Related]
7. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique.
Bouffet E; Baranzelli MC; Patte C; Portas M; Edan C; Chastagner P; Mechinaud-Lacroix F; Kalifa C
Br J Cancer; 1999 Mar; 79(7-8):1199-204. PubMed ID: 10098759
[TBL] [Abstract][Full Text] [Related]
8. Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique.
Méresse V; Vassal G; Michon J; De Cervens C; Courbon B; Rubie H; Perel Y; Landman J; Chastagnier P; De Valck C
J Clin Oncol; 1993 Apr; 11(4):630-7. PubMed ID: 8478658
[TBL] [Abstract][Full Text] [Related]
9. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Valteau-Couanet D; Michon J; Boneu A; Rodary C; Perel Y; Bergeron C; Rubie H; Coze C; Plantaz D; Bernard F; Chastagner P; Bouzy J; Hartmann O
J Clin Oncol; 2005 Jan; 23(3):532-40. PubMed ID: 15659499
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.
Philip T; Ghalie R; Pinkerton R; Zucker JM; Bernard JL; Leverger G; Hartmann O
J Clin Oncol; 1987 Jun; 5(6):941-50. PubMed ID: 3585448
[TBL] [Abstract][Full Text] [Related]
11. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.
Baranzelli MC; Patte C; Bouffet E; Portas M; Mechinaud-Lacroix F; Sariban E; Roche H; Kalifa C
J Neurooncol; 1998 May; 37(3):229-39. PubMed ID: 9524081
[TBL] [Abstract][Full Text] [Related]
12. Effect of amifostine on neuroblastoma during high dose chemotherapy: in vivo and in vitro investigations.
Renner S; Krümpelmann S; Bruchelt G; Wiesinger H; Niethammer D; Klingebiel T
Anticancer Res; 2000; 20(6B):4531-8. PubMed ID: 11205300
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.
Clarke E; Glaser AW; Picton SV
Pediatr Hematol Oncol; 2003 Sep; 20(6):467-71. PubMed ID: 14631621
[TBL] [Abstract][Full Text] [Related]
14. Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study.
Frappaz D; Michon J; Hartmann O; Bouffet E; Lejars O; Rubie H; Gentet JC; Chastagner P; Sariban E; Brugiere L
J Clin Oncol; 1992 Oct; 10(10):1592-601. PubMed ID: 1403039
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma involvement of the falx cerebri.
Quackenbush KE; Luna-Fineman S; Magee JF; Gundogan M; Golobi M; Irie T; Fernandez CV
Pediatr Blood Cancer; 2009 Dec; 53(7):1337-9. PubMed ID: 19821537
[TBL] [Abstract][Full Text] [Related]
16. The incidence of hearing impairment after successful treatment of neuroblastoma.
Simon T; Hero B; Dupuis W; Selle B; Berthold F
Klin Padiatr; 2002; 214(4):149-52. PubMed ID: 12165893
[TBL] [Abstract][Full Text] [Related]
17. Cis-platinum (CDDP) plus etoposide (VP-16-213) and treatment of disseminated neuroblastoma.
Helson L
Anticancer Res; 1986; 6(6):1337-40. PubMed ID: 3813490
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1550-2. PubMed ID: 17166384
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
